BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31610912)

  • 1. Induction of endomitosis-like event in HeLa cells following CHK1 inhibitor treatment.
    Homma H; Nojima H; Kaida A; Miura M
    Biochem Biophys Res Commun; 2019 Dec; 520(2):492-497. PubMed ID: 31610912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential properties of mitosis-associated events following CHK1 and WEE1 inhibitor treatments in human tongue carcinoma cells.
    Nojima H; Homma H; Onozato Y; Kaida A; Harada H; Miura M
    Exp Cell Res; 2020 Jan; 386(2):111720. PubMed ID: 31738907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chk1-Mad2 interaction: a crosslink between the DNA damage checkpoint and the mitotic spindle checkpoint.
    Chilà R; Celenza C; Lupi M; Damia G; Carrassa L
    Cell Cycle; 2013 Apr; 12(7):1083-90. PubMed ID: 23454898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor I receptor regulates the radiation-induced G2/M checkpoint in HeLa cells.
    Manila NG; Kaida A; Nakahama KI; Miura M
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2977-2983. PubMed ID: 30119887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sterigmatocystin-induced checkpoint adaptation depends on Chk1 in immortalized human gastric epithelial cells in vitro.
    Jiang X; Wang J; Xing L; Shen H; Lian W; Yi L; Zhang D; Yang H; Liu J; Zhang X
    Arch Toxicol; 2017 Jan; 91(1):259-270. PubMed ID: 26914363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA damage response following X-irradiation in oral cancer cell lines HSC3 and HSC4.
    Jiaranuchart S; Kaida A; Onozato Y; Harada H; Miura M
    Arch Oral Biol; 2018 Jun; 90():1-8. PubMed ID: 29522917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHK1-CENP B/MAD2 is associated with mild oxidative damage-induced sex chromosome aneuploidy of male mouse embryos during in vitro fertilization.
    Huang Y; Ha S; Li Z; Li J; Xiao W
    Free Radic Biol Med; 2019 Jun; 137():181-193. PubMed ID: 31042615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer.
    Doerr F; George J; Schmitt A; Beleggia F; Rehkämper T; Hermann S; Walter V; Weber JP; Thomas RK; Wittersheim M; Büttner R; Persigehl T; Reinhardt HC
    Sci Rep; 2017 Nov; 7(1):15511. PubMed ID: 29138515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase.
    Sakurikar N; Thompson R; Montano R; Eastman A
    Oncotarget; 2016 Jan; 7(2):1380-94. PubMed ID: 26595527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1.
    Blasina A; Hallin J; Chen E; Arango ME; Kraynov E; Register J; Grant S; Ninkovic S; Chen P; Nichols T; O'Connor P; Anderes K
    Mol Cancer Ther; 2008 Aug; 7(8):2394-404. PubMed ID: 18723486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage.
    Jackson JR; Gilmartin A; Imburgia C; Winkler JD; Marshall LA; Roshak A
    Cancer Res; 2000 Feb; 60(3):566-72. PubMed ID: 10676638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivity.
    Branigan TB; Kozono D; Schade AE; Deraska P; Rivas HG; Sambel L; Reavis HD; Shapiro GI; D'Andrea AD; DeCaprio JA
    Cell Rep; 2021 Mar; 34(9):108808. PubMed ID: 33657372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative Chk1-independent S/M checkpoint in somatic cells that prevents premature mitotic entry.
    Zineldeen DH; Shafik NM; Li SF
    Med Oncol; 2017 Apr; 34(4):70. PubMed ID: 28349497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined inhibition of Wee1 and Chk1 gives synergistic DNA damage in S-phase due to distinct regulation of CDK activity and CDC45 loading.
    Hauge S; Naucke C; Hasvold G; Joel M; Rødland GE; Juzenas P; Stokke T; Syljuåsen RG
    Oncotarget; 2017 Feb; 8(7):10966-10979. PubMed ID: 28030798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Chk1 with the small molecule inhibitor V158411 induces DNA damage and cell death in an unperturbed S-phase.
    Wayne J; Brooks T; Massey AJ
    Oncotarget; 2016 Dec; 7(51):85033-85048. PubMed ID: 27829224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Chk1 inhibition on the temporal duration of radiation-induced G2 arrest in HeLa cells.
    Nahar K; Goto T; Kaida A; Deguchi S; Miura M
    J Radiat Res; 2014 Sep; 55(5):1021-7. PubMed ID: 24894074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells.
    Ando K; Nakamura Y; Nagase H; Nakagawara A; Koshinaga T; Wada S; Makishima M
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31362335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells.
    Herůdková J; Paruch K; Khirsariya P; Souček K; Krkoška M; Vondálová Blanářová O; Sova P; Kozubík A; Hyršlová Vaculová A
    Neoplasia; 2017 Oct; 19(10):830-841. PubMed ID: 28888100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation.
    Xiao Z; Xue J; Sowin TJ; Rosenberg SH; Zhang H
    Oncogene; 2005 Feb; 24(8):1403-11. PubMed ID: 15608676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Checkpoint kinase 1 is essential for fetal and adult hematopoiesis.
    Schuler F; Afreen S; Manzl C; Häcker G; Erlacher M; Villunger A
    EMBO Rep; 2019 Aug; 20(8):e47026. PubMed ID: 31379128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.